Thymulin
Also known as: FTS, facteur thymique serique, zinc-thymulin
Thymulin is a thymic nonapeptide that becomes biologically active only when bound to zinc, after which it promotes T-cell differentiation, modulates cytokines, and participates in two-way neuroendocrine signaling.
- Drug class
- Zinc-dependent thymic peptide hormone (immunomodulatory nonapeptide)
- Primary targets
- T-cell differentiation pathways, Thymic epithelial signaling, Neuroendocrine/pituitary axis, Cytokine regulation
- Dose reference
- No established human dose; reference figures derive only from animal and gene-therapy models, not approved human labels (research-only, NOT a recommendation).
- Half-life
- Not established in humans; the native peptide is cleared rapidly from circulation, which motivated stabilized analogs and gene-therapy delivery approaches.
- Developer / origin
- Originally characterized as FTS by Jean-Francois Bach, Mireille Dardenne and colleagues (Hopital Necker/INSERM, Paris, France)
- Reference year
- 1977
- Evidence score
- 2/5 - preclinical / observational (research-only)
preclinical / observational (research-only)
Thymulin has a real peer-reviewed literature base, but it is dominated by preclinical animal/in vitro work and observational human biomarker studies. There is no FDA approval, no completed efficacy program, and no established human dosing or safety profile.
Mostly animal, ex vivo, cell, or indirect evidence.
Evidence basis
- Zinc-dependent nonapeptide structure and mechanism well characterized in vitro (Prasad; Reggiani review)
- Anti-inflammatory and analgesic effects shown only in animal/CNS models and with analogs (Dardenne 2006; Lunin 2010)
- Human data are largely observational biomarker studies tied to age, malnutrition and zinc status (Wade 1985; Chandra 1988)
- Therapeutic strategies remain preclinical gene therapy in animal models (Reggiani; Pardo 2020)
- No regulatory approval or human label establishing dose or safety
Key references
- PMCThe Thymus-Neuroendocrine Axis: Physiology, Molecular Biology, and Therapeutic Potential of the Thymic Peptide Thymulin
- PubMedPhysiology and therapeutic potential of the thymic peptide thymulin
- PMCInteractions Between Zinc and Thymulin
- PubMedNanoparticle-based thymulin gene therapy reverses key pathology of experimental allergic asthma
How to read this entry
Dose references and half-life values are pulled from trial protocols, labels, reviews, or published summaries where available. They are context for research and comparison, not a personal dosing recommendation.
Status matters: approved drugs have regulated indications; investigational compounds are still being studied; research-only peptides do not have established human dosing, safety, or efficacy for consumer use.
Thymulin guides
Read the matching guide or adjacent research pages for more context.
Peptide calculators
Use calculators for concentration, unit conversion and repeated-dose accumulation math.
Compare with related peptides
Stay inside the same research category and compare mechanism, status and evidence quality.
GHK-Cu
Copper tripeptide-1
Naturally occurring tripeptide bound to copper. Studied for wound healing, skin remodeling and gene-expression effects related to tissue repair.
Humanin
HN, MTRNR2
Humanin is a 24-amino-acid mitochondrial-derived peptide that limits stress-induced apoptosis by binding pro-apoptotic proteins (BAX, Bid/Bim) and IGFBP-3 intracellularly and by signaling extracellularly through FPR2/FPRL1 and the CNTFR/WSX-1/gp130 complex to activate JAK2/STAT3, ERK1/2 and AKT survival pathways.
Thymalin
thymus polypeptide fraction
Thymalin is a calf-thymus polypeptide complex proposed to act as an immunomodulator that promotes T-lymphocyte differentiation and maturation and normalizes cytokine and immune-cell balance, though its precise molecular receptor or target remains undefined.
Thymogen
Glutamyl-Tryptophan, gamma-glutamyl-tryptophan
Thymogen is a synthetic L-glutamyl-L-tryptophan dipeptide that acts as a thymic-peptide immunomodulator, promoting T-lymphocyte differentiation and peptide-MHC recognition, shifting IL-2 and interferon cytokine output, and enhancing neutrophil chemotaxis and phagocytosis.
Category hub
Open the category page for the full comparison table and FAQ.